Infinity Announces Key 2010 Objectives
11 janv. 2010 09h00 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today provided guidance on its...
Infinity Announces Updated Presentation Time at the J.P. Morgan Healthcare Conference
11 janv. 2010 08h43 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the company has an...
Infinity Announces Presentations at January Conferences
07 janv. 2010 15h32 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 7, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that presentations will be...
Infinity Names Adelene Q. Perkins Chief Executive Officer
07 déc. 2009 06h30 HE
|
Infinity Pharmaceuticals, Inc.
Steven H. Holtzman to Serve as Executive Chair of the Board of
Directors in Accordance With Existing Succession Plan
Transition Strategically Positions Infinity for the...
Infinity's IPI-504 Named One of Windhover and Campbell Alliance's "Top 10 Projects to Watch" in Oncology
17 nov. 2009 08h00 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Nov. 17, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Jeffrey Tong, Ph.D.,...
Adelene Q. Perkins Named "Best Executive" at Annual Stevie(R) Awards Ceremony
16 nov. 2009 09h30 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Nov. 16, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Adelene Q. Perkins,...
Infinity to Present at Upcoming Conferences
10 nov. 2009 07h30 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Nov. 10, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will...
Infinity Reports Recent R&D Highlights and Third Quarter 2009 Results
09 nov. 2009 16h00 HE
|
Infinity Pharmaceuticals, Inc.
-- Enrollment Open in All of Infinity's Ongoing Hsp90 Chaperone
Inhibitor Studies
-- Infinity Maintains Financial Strength to Advance Its Innovative
Product Pipeline
CAMBRIDGE,...
Infinity Announces Third Quarter 2009 Results Conference Call
02 nov. 2009 06h30 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Nov. 2, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced today that management will host...
Infinity Announces Appointment of Dr. Thomas J. Lynch to Its Board of Directors
07 oct. 2009 07h00 HE
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Oct. 7, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced today that Thomas J. Lynch, Jr.,...